Frank Noto
Internal Medicine · Elmhurst, NYNPI 1134232176
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $9,560 of the $15,590 with a category attached, or 61.3%. Johnson & Johnson accounts for 70.3% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2020 at $10,503 and has fallen 97.2% since, to $289 in 2024. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 76 payments — averaging $205.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$11K
- Nevro Corp.$947
- Intuity Medical Inc$524
- Mannkind Corporation$507
- Abbott$342
- AbbVie$340
- plus $2K from 16 others
What the payments were for
- Consulting fees$6004%
- Speaking & faculty fees$9,56061%
- Food & beverage$5,38235%
- Education$480%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 31 | $10,967 |
| Nevro Corp. | 9 | $947 |
| Intuity Medical Inc | 4 | $524 |
| Mannkind Corporation | 4 | $507 |
| Abbott | 4 | $342 |
| AbbVie | 3 | $340 |
| Amryt Pharma Holdings Ltd | 2 | $200 |
| Zealand Pharma US, Inc. | 2 | $181 |
| Amgen | 2 | $173 |
| Cequr Corporation | 1 | $161 |
| Biohaven Pharmaceuticals, Inc. | 1 | $150 |
| Intra-sana Laboratories | 1 | $150 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $148 |
| Nestle Healthcare Nutrition Inc. | 1 | $125 |
| Chiasma, Inc. | 1 | $125 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $125 |
| Gilead | 1 | $125 |
| AstraZeneca | 1 | $120 |
| Corcept Therapeutics | 2 | $100 |
| Ipsen Biopharmaceuticals, Inc | 2 | $45 |
| Pfizer | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$10,285
- Pogo Automatic Blood Glucose Monitoring System$524
- AFREZZA$507
- Omnia$421
- INVOKANA$339
- NURTEC ODT$298
- Senza$267
- Synthroid$250
- MYCAPSSA$237
- PROCLAIM$168
- CeQur Simplicity$161
- Reltone 200 Mg$150
- GLYCATE$150
- Reltone 400 Mg$150
- Proclaim Family of SCS IPGs$149
- Repatha$125
- ZENPEP$125
- CYCLOSET$125
- Epclusa$125
- V-GO DISPOSABLE INSULIN DELIVERY$122
How this compares
$15,590 in reported general payments places this provider in the 95th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 52 | $925 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Elmhurst
- David DoveEast Hampton$12.3M
- Bruce BergerBrooklyn$3.4M
- Nicholas RobinsonBuffalo$2.9M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Scott BeegleAlbany$1.9M
- Anthony MartinezBuffalo$1.6M
- Javier MoralesGreenvale$1.3M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.